This study examined colorectal cancer incidence rates in the United States from 2000 to 2023. It used SEER 21 data from the National Cancer Institute's SEER Program, covering 45.8% of the US population. The age-adjusted rate was 55.2 per 100,000 (95% CI 54.8 to 55.6) in 2000. By 2022 it had fallen to 36.7 per 100,000 (95% CI 36.4 to 37.0). In 2023 it rose to 38.3 per 100,000 (95% CI 38.0 to 38.6), the first rise since SEER 21 began. The authors call the 2023 increase apparent and say it warrants further surveillance and investigation.
Why it is interesting: After more than two decades of decline, colorectal cancer incidence rose in registries covering nearly half the US population. The authors call the 2023 rise apparent and say it needs further surveillance and investigation.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.
Other drivers in Health today
-
Cancer
Where is cancer incidence rising and falling, what screening and new tests find earlier, and what treatment has done to survival.
13 this week -
Obesity, diabetes and GLP-1
Are obesity and diabetes still rising, what behavioural change and public policy do, and what difference do GLP-1s and other similar drugs make.
11 this week -
Heart and stroke
Whether deaths from heart disease and stroke have stopped falling, what is found earlier, what treatment and prevention do now, and what the deaths say.
6 this week -
Mental health
Deaths by suicide, the life expectancy gap in severe mental illness, and the physical disease that follows it: what mental illness costs in lives.
6 this week -
Dementia
Whether dementia is becoming more or less common, what is now found, what treatment and prevention do, and what the deaths say.
6 this week -
Frailty and multimorbidity
Whether the years added after 85 are healthy ones, how frailty and multiple conditions are measured, and where the data run out.
1 this week
